Medistim ASA (FRA:MD1)

Germany flag Germany · Delayed Price · Currency is EUR
20.50
+0.30 (1.49%)
Last updated: Oct 22, 2025, 8:00 AM CET
1.49%
Market Cap376.03M
Revenue (ttm)52.87M
Net Income (ttm)11.04M
Shares Outn/a
EPS (ttm)0.60
PE Ratio34.07
Forward PE29.73
Dividend0.51 (2.70%)
Ex-Dividend DateMay 9, 2025
Volumen/a
Average Volume7
Open20.50
Previous Close20.20
Day's Range20.50 - 20.50
52-Week Range11.10 - 22.70
Betan/a
RSI53.45
Earnings DateOct 24, 2025

About Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplan... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 1984
Employees 154
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol MD1
Full Company Profile

Financial Performance

In 2024, Medistim ASA's revenue was 556.16 million, an increase of 6.73% compared to the previous year's 521.11 million. Earnings were 103.83 million, an increase of 0.01%.

Financial numbers in NOK Financial Statements

News

There is no news available yet.